Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Taiwanese (TAIEX) Pharma Industry Analysis

UpdatedAug 18, 2025
DataAggregated Company Financials
Companies56
  • 7D4.1%
  • 3M20.1%
  • 1Y0.08%
  • YTD15.6%

Over the last 7 days, the Pharma industry has risen 4.1%, driven by gains from Caliway Biopharmaceuticals of 10%. In the same time, Lotus Pharmaceutical was down 9.5%. Despite this gain, the industry's performance has been flat over the past year. As for the next few years, earnings are expected to grow by 58% per annum.

Industry Valuation and Performance

Has the Taiwanese Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 18 Aug 2025NT$724.6bNT$118.5bNT$10.4b15.7x69.8x6.1x
Wed, 16 Jul 2025NT$462.4bNT$116.0bNT$14.8b18.4x31.2x4x
Fri, 13 Jun 2025NT$637.6bNT$115.9bNT$14.3b19.1x44.7x5.5x
Sun, 11 May 2025NT$569.9bNT$113.7bNT$10.5b20.4x54.3x5x
Tue, 08 Apr 2025NT$527.5bNT$112.8bNT$10.8b16.5x48.7x4.7x
Thu, 06 Mar 2025NT$674.6bNT$109.4bNT$11.9b23.6x56.9x6.2x
Sat, 01 Feb 2025NT$612.0bNT$109.3bNT$11.4b21.7x53.5x5.6x
Mon, 30 Dec 2024NT$599.4bNT$109.3bNT$11.4b22.2x52.4x5.5x
Wed, 27 Nov 2024NT$639.5bNT$109.5bNT$11.5b21.9x55.5x5.8x
Fri, 25 Oct 2024NT$633.7bNT$104.7bNT$8.9b28.3x70.9x6.1x
Sun, 22 Sep 2024NT$634.3bNT$104.7bNT$8.9b24.9x70.9x6.1x
Tue, 20 Aug 2024NT$654.9bNT$104.8bNT$8.9b26.3x73.2x6.3x
Thu, 18 Jul 2024NT$711.4bNT$100.5bNT$6.8b32.4x104.2x7.1x
Sat, 15 Jun 2024NT$638.9bNT$100.4bNT$7.2b30x89.3x6.4x
Mon, 13 May 2024NT$614.8bNT$102.3bNT$9.4b27x65.3x6x
Wed, 10 Apr 2024NT$706.9bNT$101.5bNT$9.2b26.8x76.8x7x
Fri, 08 Mar 2024NT$652.9bNT$101.9bNT$8.6b24.6x76.1x6.4x
Sun, 04 Feb 2024NT$596.7bNT$101.9bNT$7.8b23.7x76.6x5.9x
Tue, 02 Jan 2024NT$580.1bNT$101.9bNT$7.8b23.9x74.4x5.7x
Thu, 30 Nov 2023NT$582.1bNT$101.6bNT$7.7b24x76.1x5.7x
Sat, 28 Oct 2023NT$557.5bNT$101.7bNT$9.7b21.7x57.5x5.5x
Mon, 25 Sep 2023NT$544.5bNT$101.7bNT$9.6b22x56.6x5.4x
Wed, 23 Aug 2023NT$543.1bNT$101.7bNT$9.6b21.6x56.3x5.3x
Fri, 21 Jul 2023NT$595.5bNT$98.7bNT$10.1b17.1x59.2x6x
Sun, 18 Jun 2023NT$583.7bNT$98.6bNT$10.1b16.9x58.1x5.9x
Tue, 16 May 2023NT$552.3bNT$92.2bNT$8.6b19.3x64x6x
Thu, 13 Apr 2023NT$582.3bNT$91.2bNT$8.5b21x68.4x6.4x
Sat, 11 Mar 2023NT$543.4bNT$85.1bNT$6.8b21.2x79.4x6.4x
Mon, 06 Feb 2023NT$507.8bNT$84.6bNT$7.9b21x64.4x6x
Wed, 04 Jan 2023NT$499.7bNT$84.6bNT$7.9b21.1x63.4x5.9x
Fri, 02 Dec 2022NT$488.3bNT$84.6bNT$7.9b16.3x61.9x5.8x
Sun, 30 Oct 2022NT$389.9bNT$79.1bNT$4.3b17x89.6x4.9x
Tue, 27 Sep 2022NT$430.2bNT$78.9bNT$4.3b17.5x99.4x5.4x
Thu, 25 Aug 2022NT$455.7bNT$78.9bNT$4.3b18.5x105.2x5.8x
Price to Earnings Ratio

105.2x


Total Market Cap: NT$455.7bTotal Earnings: NT$4.3bTotal Revenue: NT$78.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Pharma Industry Price to Earnings3Y Average 67.4x202320242025
Current Industry PE
  • Investors are relatively neutral on the Taiwanese Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 67.4x.
  • The industry is trading close to its 3-year average PS ratio of 5.9x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 34% per year over the last three years.
  • Revenues for these companies have grown 14% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare industry?

TW Market1.39%
Healthcare1.70%
Pharma4.05%
Pharma4.05%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6919 Caliway BiopharmaceuticalsNT$159.5021.8%
+NT$44.2b		141.7%PS5518.1x
6472 Bora PharmaceuticalsNT$778.008.7%
+NT$7.7b		27.0%PE18.8x
6535 Lumosa TherapeuticsNT$173.5023.9%
+NT$5.6b		-31.2%PS784.6x
4743 Oneness BiotechNT$70.308.8%
+NT$2.7b		-53.6%PS298.7x
6467 Taho PharmaceuticalsNT$133.5034.2%
+NT$1.7b		n/aPS881.9x

Latest News

6838
NT$32.90
Formosa Pharmaceuticals
7D
7.9%
1Y
-15.6%
6620
NT$78.30
Handa Pharmaceuticals
7D
-4.6%
1Y
-7.0%
4114
NT$35.70
Synmosa Biopharma
7D
-8.2%
1Y
4.2%
1795
NT$194.00
Lotus Pharmaceutical
7D
-9.8%
1Y
-30.3%
6919
NT$159.50
Caliway Biopharmaceuticals
7D
21.8%
1Y
141.7%
3705
NT$55.80
YungShin Global Holding
7D
-2.1%
1Y
-3.3%
6472
NT$778.00
Bora Pharmaceuticals
7D
8.7%
1Y
27.0%
4743
NT$70.30
Oneness Biotech
7D
8.8%
1Y
-53.6%
6535
NT$173.50
Lumosa Therapeutics
7D
23.9%
1Y
-31.2%
1789
NT$17.65
ScinoPharm Taiwan
7D
6.0%
1Y
-30.2%
6785
NT$173.50
Alar Pharmaceuticals
7D
-3.6%
1Y
-21.1%
1271
NT$88.20
SunWay Biotech
7D
12.6%
1Y
0.8%
6467
NT$133.50
Taho Pharmaceuticals
7D
34.2%
1Y
n/a
7759
NT$69.50
Sunhawk Vision Biotech
7D
-3.3%
1Y
n/a
6586
NT$37.30
CHO Pharma
7D
-4.0%
1Y
-39.7%